TherapeuticsMD (TXMD) Misses Q2 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to TherapeuticsMD (TXMD) Misses Q2 EPS by 5c

TherapeuticsMD Announces Second Quarter 2015 Financial Results  

August 6, 2015 4:05 PM EDT

Completed Enrollment of 700 Patients in Phase 3 Rejoice Trial; Topline Data Anticipated in Fourth Quarter of 2015 Patient Recruitment for Phase 3 Replenish Trial Advancing; Enrollment Completion Expected during Second Half of 2015 Management to Host Conference call Today at 4:30 p.m. EDT

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative womens healthcare company, today announced its second quarter financial results for the period ended June 30, 2015.

Second Quarter and Recent Developments

... More